2015, the year that was: Health + Medicine

2015 was the year of the health review – on mental health care, the response to ice, Medicare, private health insurance, the pharmacy industry … and the list goes on.
But while little new policy was announced in 2015, debates continued about where the health system should be headed.

Keeping a lid on rising health costs

After 17 months on life support, the GP co-payment finally died and was “burned and cremated” in March. Just as well; while the co-payment mark II was reduced to A$5, non-concession patients may have ended end up paying a A$30 more, according to Grattan Institute analysis.
We don’t have a co-payment but Australians are still likely to pay more for GP visits because of the rebate freeze.
Rido/Shutterstock
The Coalition tried to justify its failed GP co-payment as an attempt to rein in consumers, who were driving the increase in Medicare costs. But it turns out government policy was mostly to blame.
As Stephen Duckett wrote in November:

The co-payment proposal sank like a lead balloon partly because it was seen as inefficient and unfair, but also because the public didn’t have any ownership of the “problem” the changes sought to address.

However, the freeze on GP fees remains, some of which may be passed on to consumers.
An analysis by the University of Sydney’s BEACH researchers shows that freezing GP earnings until 2017-18 equates to a 7.1% cut in real terms. Assuming this cut is passed on to non-concesssional patients, each visit would cost around A$8 more.
Most experts agree the key to a more sustainable health system is to better coordinate the care of the sick and elderly who use a disproportionate amount of health care. Just 12.5% of the population account for 41% of costs, and older people are using more and more health services.
A small group of patients use almost half of the primary health resources.
lauren rushing/Flickr, CC BY-NC-ND
Paying doctors a fixed sum to care for a patient for the entire year, rather than a fee for each visit or service, is one solution, Peter Sivey wrote.
Another is to better target the tests and treatments that are given, and to tame the tsunami of too much medicine, Ray Moynihan explained. The current review of the Medicare schedule presents an opportunity to do just this.
Another key review currently underway is investigating the private health insurance industry. Premiums increased by an average of 6.2% in April, well above CPI and annual health inflation.
Private health insurance rebate increases vs CPI and health inflation.
The Conversation, CC BY
In response to this rise, we published a six-part series and infographic investigating why half of Australians have private health insurance, how the carrot and stick private health insurance reforms have failed and the options for reform.
We’ll bring you more next year when the private health insurance review is complete.

The thalidomide tragedy

This month we ran a 13-part series on thalidomide, the drug that caused thousands of miscarriages in the late 1950s and early ‘60s and left more than 10,000 children severely disabled.
We explored the history of the scandal: how the drug was developed and marketed, how the manufacturer ignored warnings it was causing harm, and whether something similar could happen today.
Our timeline and at-a-glance infographic provided a snapshot of how it unfolded.

The Conversation – part of our thalidomide infographic., CC BY
Then we heard from the victims who are still struggling to gain compensation and are experiencing a new range of ageing-related conditions, exacerbated by their disability.
Starting near the end of World War II and continuing until the 1970s, the US government sponsored radiation experiments on human subjects.
Exercise Desert Rock I Buster Jangle Dog. By Federal Government of the United States [Public domain], CC BY
Finally, we looked at the impact of the tragedy on regulation, women’s fear about taking medicines during pregnancy, and how thalidomide is used today to treat conditions such as leprosy and bone cancer.
This followed our broader historical series in June on human experimentation, which explored the chequered history of wartime experiments and how these wrongs shaped medical ethics.

Other key series and packages

We think of pain as something that strikes certain parts of our body when something is damaged, but it’s much more complicated than that. Our ten-part series on pain examined the economic and social costs of chronic pain, how we experience and talk about pain, and the gender, cultural and psychological differences at play.
Our weekly consumer Health Check series continued and generated popular discussion on food comas, whether your brain can be “full”, and why some people feel the cold more than others.
Our in-depth packages examined how hormones affect our mood, sleep and satiety; and the issues surrounding IVF and donor conception, including a reader-expert Your Questions Answered forum.
Our experts in law, embryology, sociology and psychology answered your questions on IVF and donor conception.
Philippe Put/Flickr, CC BY
We also canvassed some controversial but innovative options for tobacco control: prohibit the sale of tobacco to people born after 2000, make cigarettes less palatable, target the supply
and introduce a smoker’s licence.
Fron Jackson-Webb, Section Editor, Health and Medicine, The Conversation
This article was originally published on The Conversation. Read the original article.